$1.75
2.94%
Nasdaq, Oct 02, 04:00 pm EDT. Closed.
ISIN
US42225T1079
Symbol
HCAT

Health Catalyst Inc Target price 2026 - Analyst rating & recommendation

Health Catalyst Inc Classifications & Recommendation

Buy
50%
Hold
50%

Health Catalyst Inc Price Target

Target Price $1.94
Price $1.75
Potential
Number of Estimates 6
6 Analysts have issued a price target Health Catalyst Inc 2027 . The average Health Catalyst Inc target price is $1.94. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 6 Analysts recommend Health Catalyst Inc to buy, 6 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Health Catalyst Inc stock has an average upside potential 2027 of . Most analysts recommend the Health Catalyst Inc stock at Buy or hold.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 311.14 252.68
1.49% 18.79%
EBITDA Margin 4.63% 7.39%
201.71% 59.68%
Net Margin -57.20% -1.37%
152.32% 97.60%

8 Analysts have issued a sales forecast Health Catalyst Inc 2026 . The average Health Catalyst Inc sales estimate is

$253m
unlock
. This is
13.54% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$263m 10.00%
unlock
, the lowest is
$241m 17.39%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $311m 1.49%
2026
$253m 18.79%
unlock
2027
$212m 16.14%
unlock
2028
$230m 8.37%
unlock

8 Analysts have issued an Health Catalyst Inc EBITDA forecast 2026. The average Health Catalyst Inc EBITDA estimate is

$18.7m
unlock
. This is
31.44% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$20.1m 26.20%
unlock
, the lowest is
$17.6m 35.29%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $14.4m 203.23%
2026
$18.7m 29.65%
unlock
2027
$7.1m 61.91%
unlock
2028
$13.2m 84.94%
unlock

EBITDA Margin

2025 4.63% 201.71%
2026
7.39% 59.68%
unlock
2027
3.36% 54.53%
unlock
2028
5.73% 70.54%
unlock

8 Health Catalyst Inc Analysts have issued a net profit forecast 2026. The average Health Catalyst Inc net profit estimate is

$-3.5m
unlock
. This is
98.70% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$0.0 100.00%
unlock
, the lowest is
$-6.4m 97.60%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-178m 156.07%
2026
$-3.5m 98.06%
unlock
2027
$590k 117.10%
unlock
2028
$6.7m 1,028.81%
unlock

Net Margin

2025 -57.20% 152.32%
2026
-1.37% 97.60%
unlock
2027
0.28% 120.44%
unlock
2028
2.90% 935.71%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -2.55 -0.05
121.74% 98.04%
P/E negative
EV/Sales 0.72

8 Analysts have issued a Health Catalyst Inc forecast for earnings per share. The average Health Catalyst Inc EPS is

$-0.05
unlock
. This is
98.60% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$0.00 100.00%
unlock
, the lowest is
$-0.09 97.49%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-2.55 121.74%
2026
$-0.05 98.04%
unlock
2027
$0.01 120.00%
unlock
2028
$0.09 800.00%
unlock

P/E ratio

Current -0.49 75.04%
2026
-37.79 7,631.18%
unlock
2027
219.96 682.06%
unlock
2028
19.61 91.08%
unlock

Based on analysts' sales estimates for 2026, the Health Catalyst Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.62 22.50%
2026
0.72 16.00%
unlock
2027
0.86 19.26%
unlock
2028
0.79 7.72%
unlock

P/S ratio

Current 0.45 27.72%
2026
0.52 15.67%
unlock
2027
0.62 19.24%
unlock
2028
0.57 7.71%
unlock

Current Health Catalyst Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Canaccord Genuity
Locked
➜
Locked
Locked Aug 21 2026
Wells Fargo
Locked
➜
Locked
Locked Aug 13 2026
Citigroup
Locked
➜
Locked
Locked Aug 11 2026
Canaccord Genuity
Locked
➜
Locked
Locked Jul 21 2026
Wells Fargo
Locked
➜
Locked
Locked Jun 26 2026
Stephens & Co.
Locked
➜
Locked
Locked May 12 2026
Wells Fargo
Locked
➜
Locked
Locked Mar 18 2026
Analyst Rating Date
Locked
Canaccord Genuity:
Locked
➜
Locked
Aug 21 2026
Locked
Wells Fargo:
Locked
➜
Locked
Aug 13 2026
Locked
Citigroup:
Locked
➜
Locked
Aug 11 2026
Locked
Canaccord Genuity:
Locked
➜
Locked
Jul 21 2026
Locked
Wells Fargo:
Locked
➜
Locked
Jun 26 2026
Locked
Stephens & Co.:
Locked
➜
Locked
May 12 2026
Locked
Wells Fargo:
Locked
➜
Locked
Mar 18 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today